Effect of Emotional Freedom Technique and Diaphragmatic Breathing on Post Traumatic Stress Disorder (PTSD)
Stress Disorders, Post-Traumatic
Behavioral: Emotional Freedom Techniques (EFT)
|Study Design:||Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Double Blind (Subject, Outcomes Assessor)
Primary Purpose: Treatment
|Official Title:||Effect of Emotional Freedom Technique and Diaphragmatic Breathing on PTSD|
- Change in baseline cortisol and DHEA production [ Time Frame: Six months ]
- Changes in scores on Trauma Assessment Inventory and other instruments normed for trauma [ Time Frame: Six months ]
|Study Start Date:||September 2007|
|Study Completion Date:||January 2009|
|Primary Completion Date:||January 2009 (Final data collection date for primary outcome measure)|
The Purpose of the Research: The purpose of this study is to test the effectiveness of Emotional Freedom Technique (EFT) versus Diaphragmatic Breathing in Reducing Post Traumatic Stress Disorders.
The Scientific or Scholarly Rationale: Clinical experience and anecdotal reports have demonstrated EFT to be effective for a wide range of behavioral disorders, including PTSD. However with the exception of several studies demonstrating the efficacy of EFT for the treatment of simple phobias, there have been no formal research studies in this area. It is the intention of this study to extend the phobia studies to the area of PTSD, and to determine what other conditions EFT might be effective in treating. Another intention of this study is to see whether, and to what degree, changes in psychological functioning (as measure by the PAI and TSI) are reflected in physiological markers such as HRV (Heart Rate Variability) and levels of cortisol and DHEA.
The Procedures to be Performed: Approximately 8 to 10 subjects would be randomly designated to either the experimental or Diaphragmatic Breathing control groups. There will be 4-5 subjects in the EFT experimental group and 4-5 subjects in the control Diaphragmatic Breathing group.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00514956
|United States, West Virginia|
|Marshall University Medical School|
|Charleston, West Virginia, United States|
|Marshall University, Joan Edwards School of Medicine|
|Huntington, West Virginia, United States, 25701|
|Study Director:||Dawson Church, PhD||Soul Medicine Institute|